Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Biphasic Pattern	NCIT_C35907
Monophasic Pattern	NCIT_C35908
Pseudofollicular Pattern	NCIT_C35901
Interfollicular Pattern	NCIT_C35902
Diffuse Pattern	NCIT_C35903	[A morphologic architectural pattern in which a cellular population is distributed in a relatively uniform fashion throughout a specified tissue area; not focal.]
Nodular and Diffuse Pattern	NCIT_C35904
Multinodular Pattern	NCIT_C35900
Start Procedure Action Item	NCIT_C69263	[Indicates the beginning action of a procedure.]
End Procedure Action Item	NCIT_C69264	[Indicates the ending action of a procedure.]
Image Acquired	NCIT_C69265	[An indication that an image has been successfully captured and saved.]
Acquisition	NCIT_C43384	[The process by which something is acquired or obtained.]
Fibromun	NCIT_C94210	[An immunocytokine consisting of human pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha) fused to a human single-chain variable fragment (scFv) directed against the extra-domain B (ED-B) of fibronectin (L19), with potential immunopotentiating and antineoplastic activities. The L19 moiety of recombinant human fusion protein L19TNFalpha binds to the ED-B domain of fibronectin on tumor cells in the tumor neovasculature. In turn, the TNFalpha moiety may locally induce an immune response against ED-B fibronectin-expressing tumor cells and may specifically decrease the proliferation of ED-B-expressing tumor cells. ED-B is predominantly expressed during angiogenesis and tumor growth.]
Glioblastoma Multiforme Multipeptide Vaccine IMA950	NCIT_C94211	[A cancer vaccine comprised of 11 peptides associated with glioblastoma multiforme (GBM), with potential immunomodulating and antineoplastic activities. Vaccination with glioblastoma multiforme multi-antigen vaccine IMA950 stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response as well as a T-helper (Th) immune response against tumor cells expressing these peptides, potentially resulting in decreased tumor growth of GBM. Peptides in IMA950 consist of the following: brevican (BCAN); chondroitin sulfate proteoglycan 4 (CSPG4); fatty acid binding protein 7, brain (FABP7); insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3); neuroligin 4, X-linked (NLGN4X); neuronal cell adhesion molecule (NRCAM); protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1); tenascin C (TNC); Met proto-oncogene (MET); baculoviral IAP repeat-containing 5 (BIRC5); and hepatitis B virus core antigen.]
Peptide Vaccine	NCIT_C1752	[A vaccine based on a synthetic peptide or peptides produced from tissue samples or recombinant sources. Vaccination with peptide vaccines may elicit host immune responses against antigen-expressing cells.]
Number of Frames	NCIT_C69267	[The total number of frames in a multiframe image.]
Number	NCIT_C25337	[A numeral or string of numerals expressing value, quantity, or identification.]
Fluorodeoxygalactose F-18	NCIT_C94212	[A radioconjugate containing the D-galactose analogue 2-deoxy-2-fluoro-D-galactose (FDGal) labeled with the positron-emitting radioactive isotope fluorine F18, used for imaging upon positron emitting tomography (PET). With cell uptake much higher in tumor cells compared to normal cells, the F18 moiety of fluorodeoxygalactose F-18 can be visualized upon PET imaging and this agent can be used as a tracer for the evaluation of galactose tumor uptake and metabolism.]
Image Type	NCIT_C69268	[A category of image.]
Type	NCIT_C25284	[Something distinguishable as an identifiable class based on common qualities.]
Choline Kinase Alpha Inhibitor TCD-717	NCIT_C94213	[A small-molecule inhibitor of choline kinase alpha (CHKA), with potential antineoplastic activity. TCD-717 targets and binds to CHKA, an enzyme that plays a key role in the synthesis of phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. Blockade of this enzyme induces cells to activate a different route for phospholipid production which causes a toxic effect and eventually leads to cell destruction. CHKA, overexpressed in human cancer cells while only minimally expressed in normal cells, appears to play a significant role in cellular proliferation, evasion of apoptosis, increased cell motility and metastasis.]